Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device -- Ignore unavailable to you. Want to Upgrade?

To: (no name provided) who wrote (107)	3/19/1998 10:51:00 PM
From: Dante Sinferno	Read Replies (1) \| Respond to of 246

<<when the FDA revokes their ability to sell this product.>> Can you elaborate ? Why would FDA give approval and then take it away.....what has changed ? Rob

To: (no name provided) who wrote (107)	3/20/1998 8:28:00 AM
From: MaximilianII	Read Replies (1) \| Respond to of 246

Start-up companies such as Humascan attract seed capital from venture capitalists and other aggressive investors seeking a substantial ROI within a relatively short period. As I stated, there are investors which have unloaded a portion of their shares to free up capital for new investment. I do not view this as a negative signal. Cashing out a portion of an initial investment (recognizing a ROI of 1000+%) in order to invest in a new venture is how fortunes are accumulated. Besides, many of these investors are still holding substantial stakes in HMSC. HMSC also attracted a lot of new investors at prices between $10-13.5, some of which were large institutions (which do in fact conduct due diligence before committing capital). I'd like to hear concrete reasons behind why you think HMSC is doomed, reflecting your due diligence review.